Nakatsu, Japan

Masami Hirano

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masami Hirano. Retrieved from https://idiyas.com/inventor/masami-hirano-a4a9d11o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masami Hirano: Innovator in Pharmaceutical Chemistry

Introduction

Masami Hirano is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of penicillanic acid compounds. His work has implications for the development of antibiotics and other medicinal compounds.

Latest Patents

Hirano holds a patent for a process for the production of penicillanic acid compounds. This patent describes an improved method for producing chloromethyl esters of penicillin G, penicillin V, or sulbactam. His innovative approach enhances the efficiency and effectiveness of these important pharmaceutical compounds.

Career Highlights

Masami Hirano is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been instrumental in advancing research and development in pharmaceutical products. His expertise in the field has led to significant advancements in antibiotic production.

Collaborations

Hirano has worked alongside talented colleagues, including Kazuto Tsukinuki and Kazumi Saeki. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Masami Hirano's contributions to pharmaceutical chemistry, particularly through his patent on penicillanic acid compounds, highlight his role as an innovator in the industry. His work continues to influence the development of essential medicinal products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…